Evaluation of polypectomy quality indicators of large nonpedunculated colorectal polyps in a nonexpert, bowel cancer screening cohort

• Published in: Gastrointestinal endoscopy Vol. 94; no. 6; pp. 1085 - 1095.e2
• Main Authors: Meulen, Lonne W.T., van der Zander, Quirine E.W., Bogie, Roel M.M., Keulen, Eric T.P., van Nunen, Annick B., Winkens, Bjorn, Straathof, Jan Willem A., Hoge, Chantal V., de Ridder, Rogier, Moons, Leon M.G., Masclee, Ad A.M.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2021
• Subjects: Colonic Polyps - diagnosis; Colonic Polyps - surgery; Colonoscopy; Colorectal Neoplasms - diagnosis; Colorectal Neoplasms - surgery; Cross-Sectional Studies; Early Detection of Cancer; Humans; Quality Indicators, Health Care; FIT; LNPCP; BCSP; SMIC; SMSA
• ISSN: 0016-5107; 1097-6779
• DOI: 10.1016/j.gie.2021.06.008

With the introduction of the national bowel cancer screening program, the detection of sessile and flat colonic lesions ≥20 mm in size, defined as large nonpedunculated colorectal polyps (LNPCPs), has increased. The aim of this study was to examine the quality of endoscopic treatment of LNPCPs in the Dutch screening program. This investigation comprised 2 related, but separate, substudies (1 with a cross-sectional design and 1 with a longitudinal design). The first examined prevalence and characteristics of LNPCPs in data from the national Dutch screening cohort from February 2014 until January 2017. The second, with screening data from 5 endoscopy units in the Southern part of the Netherlands from February 2014 until August 2015, examined performance on important quality indicators (technical and clinical successes, recurrence rate, adverse event rate, and surgery referral rate). All patients were part of the national Dutch screening cohort. In the national cohort, an LNPCP was detected in 8% of participants. Technical and clinical success decreased with increasing LNPCP size, from 93% and 96% in 20- to 29-mm lesions to 85% and 86% in 30- to 39-mm lesions and to 74% and 81% in ≥40-mm lesions (P < .001; P = .034). The cumulative recurrence rate at 12 months increased with LNPCP size, from 9% to 22% and 26% in the respective size groups (P = .095). The adverse event rate was 5%. The overall surgical referral rate for noninvasive LNPCPs was 7%. In this performance of 2 substudies, it was shown that quality parameters for endoscopic resection of large polyps in the Dutch screening cohort are not reached, especially in ≥30-mm polyps. Endoscopic resection of large polyps could benefit from additional training, quality monitoring, and centralization either within or between centers. [Display omitted]